The resulting fusion proteins AF4-MLL (der4) and MLL-AF4 (der11) lead to development and maintenance of high-risk acute lymphoblastic leukemia (ALL) [14, 17–19]. Here, KMT2A is linked to acute lymphoblastic leukemia.